The vaccine production on SARS-CoV-2 will start before the tests are completed
The American National Institute of Allergy and Infectious Diseases has just announced that by the end of the year, the United States will have 100 million vaccines for SARS-CoV-2 coronavirus. Their production will start before the end of clinical trials. The plan was presented by the director of the National Institute of Allergy and Infectious Diseases and a member of the White House task force for coronavirus – Dr. Anthony Fauci. It is a vaccine from Moderna mRNA-1273 , which was designed with the virus proteins responsible for infecting human cells in mind. Coronavirus vaccine After its administration, the immune system of vaccinated people will develop appropriate antibodies in advance, which will make SARS-CoV-2 unable to attach itself to humans. In the first phase of clinical testing, the desired vaccine effect was observed in eight volunteers. Fauci announced that the final stage of clinical testing of mRNA-1273 vaccine will start around mid-summer. In this last, third phase...